Keisuke Taniuchi
5PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 10, 2025
Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors.Yuri Jobu, Miki Nishigawa, Kaoru Furihata
|Mar 11, 2022
Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.Keisuke Taniuchi, Makoto Ueno, Tomoyuki Yokose
|Feb 12, 2022
Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid.Chiharu Tanaka, Kaoru Furihata, Seiji Naganuma
|Jun 06, 2019
Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients.Keisuke Taniuchi, Mutsuo Furihata, Seiji Naganuma
|Oct 25, 2018
WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.Keisuke Taniuchi, Mutsuo Furihata, Seiji Naganuma
Pageof 1
